Home

Pharmaids Pharmaceuticals Ltd EPS

Image

Pharmaids Pharmaceuticals Ltd

NSE: PHARMAIDSPHARMA

EPS

₹ -3.46

Last updated on: Apr 17, 2025

Key Highlights

  • The Earning per Share of Pharmaids Pharmaceuticals Ltd is ₹ -3.46 as of 17 Apr 25 .
  • The earning per share of Pharmaids Pharmaceuticals Ltd changed from ₹ -0.61 to ₹ -0.55 over 7 quarters. This represents a CAGR of -5.74% .

Historical Earning per Share of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Pharmaids Pharmaceuticals Ltd

Market Cap

227 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

3.4

Day’s High

70.69

Day’s Low

64.0

DTE

0.2

ROE

-17.2

52 Week High

87.46

52 Week Low

31.9

ROCE

-17.9

Market Price of Pharmaids Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Pharmaids Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Apr 202564.39
16 Apr 202565.99
15 Apr 202567.38
11 Apr 202565.5
09 Apr 202566.99
08 Apr 202566.09
07 Apr 202565
04 Apr 202568.63
03 Apr 202569.99
02 Apr 202568.11

BlinkX Score for Pharmaids Pharmaceuticals Ltd

Asset Value vs Market Value of Pharmaids Pharmaceuticals Ltd

Market Value

227

Asset Value

Value addition

10.1 X

20

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Pharmaids Pharmaceuticals Ltd227.09
Sun Pharmaceutical Industries Ltd420136
Divis Laboratories Ltd149680
Cipla Ltd122390
Torrent Pharmaceuticals Ltd110154
Mankind Pharma Ltd106555

Historical Market Cap of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Pharmaids Pharmaceuticals Ltd News Hub

Pharmaids Pharmaceuticals to convene board meeting

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 August

Read more

21 Aug 24

Pharmaids Pharmaceuticals reports consolidated net loss of Rs 2.68 crore in the June 2024 quarter

Net Loss of Pharmaids Pharmaceuticals reported to Rs 2.68 crore in the quarter ended June 2024 as ag

Read more

14 Aug 24

Pharmaids Pharmaceuticals schedules board meeting

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August

Read more

07 Aug 24

Pharmaids Pharmaceuticals AGM scheduled

Pharmaids Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the company will b

Read more

03 Sept 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Pharmaids Pharmaceuticals Ltd

What is the EPS of Pharmaids Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Pharmaids Pharmaceuticals Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Pharmaids Pharmaceuticals Ltd EPS calculated?

The EPS of Pharmaids Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Pharmaids Pharmaceuticals Ltd report its EPS?

Pharmaids Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Pharmaids Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Pharmaids Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Pharmaids Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Pharmaids Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions